Defence Therapeutics Inc.
DTC
Rangering i aksjer
#29526
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aksjekurs
$0.25964327
Sist synkronisert: 2026-10-21
Markedsverdi
$19.68M
Endring (1 dag)
0.00%
Endring (1 år)
-55.64%
Land
CA
Handel Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Aksjeprishistorikk for Defence Therapeutics Inc. (DTC)
Høyeste sluttskurs: $0.27 den 2026-10-01
Laveste sluttskurs: $2.50 den 2021-05-01
Laveste sluttskurs: $2.50 den 2021-05-01
Aksjeprishistorikk for Defence Therapeutics Inc. fra 2021 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | -27.66% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.19 | -4.22% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
